Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05449418 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities

Study acronym: ENSPIRE
StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
  2. Minor Re-verified, no change to tracked fieldsv5
  3. Notable Primary completion date: Dec 31, 2023 to Jul 31, 2024
    • Study completion date: Nov 2024 to Feb 28, 2026
    v4
  4. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 5000 to confirmed 988
    • Primary completion date changed from estimate of Nov 2024 to Dec 31, 2023
    • Site details revised at 2 of 2 sites
    v3
  5. Minor Site contacts updated at 1 of 2 sitesv2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The ENSPIRE study is a cluster-randomized comparative effectiveness trial being conducted within long-term care and residential facilities that will test a communication and engagement strategy for increasing COVID-19 booster vaccination rates against an enhanced usual care comparator (Centers for Disease Control and Prevention or other national organization vaccine education and communication materials) among facility staff. The communication and engagement strategy being tested includes (1) the development of materials co-designed with and tailored to facility staff whose primary language is a language other than English or who are from certain cultural affinity groups and (2) the distribution of the developed materials by members of the language/cultural affinity groups with peer advocacy activities (full intervention). The study is being conducted in Washington state and Georgia. Long-term care/residential facilities will be asked to furnish their staff booster rate at 4 timepoints: pre-intervention, and one month (timepoint 1), 3 months (timepoint 2), and 6 months (timepoint 3) post-intervention. Staff at participating long-term care facilities will be invited to complete three online surveys at 3 timepoints: pre-intervention, 3 months post-intervention and 6 months post-intervention. Long-term care facilities will be randomized to a trial arm following the pre-intervention data collection.
Trial Details
NCT Number NCT05449418
Lead Sponsor Kaiser Permanente
Collaborators: Patient-Centered Outcomes Research Institute, Global Alliance to Prevent Prematurity and Stillbirth (GAPPS)
Conditions
(from sponsor)
COVID-19
Related terms COVID-19
Enrollment 988 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov